On April 12th, Head Group showcased Headcel® pharmaceutical grade cellulose ether and Healsee capsules at the 2023 API China exhibition, booth number S6J07. API China focuses on improving the overall level of production and research and development of pharmaceutical raw materials, intermediate drugs and auxiliary materials in China's pharmaceutical industry, and has become a brand event for industry leaders to showcase advanced product technology, interpret policies and regulations, enhance industry production levels and reflect industry development trends. The 88th API China and the 26th CHINA-PHARM were held at the Qingdao World Expo City International Exhibition Center in Shandong for a period of three days. Head looks forward to meeting you at booth S6J07 to explore industry development together.
As one of the most important dosage forms in solid oral preparations, the design and functionality of capsule preparations have also been continuously improving with the development of drug research and development technology, material science, and equipment engineering. At this API exhibition, Healsee capsules also brought a full range of plant-based capsule products, including HPMC plant-based capsules, enteric-coated capsules, acid-resistant capsules, second-generation pure capsules, etc.
In the future, whether it's technological innovation or new product development and manufacturing, Head Group hopes to bring more product solutions to benefit more businesses and consumers.
